South Korea is to begin trials of an experimental plasma treatment for Middle East Respiratory Syndrome which has now killed 19 people.
The treatment - which has already proved useful for tackling other deadly diseases, including Ebola - uses blood from patients who have successfully fought off the same infection.
To date, more than 150 people in the country have been infected with Mers. The South Korean health ministry said two hospitals would begin the plasma treatment trials.
There is currently no cure or vaccine that can protect people from Mers. Though officials still emphasise that the number of new cases is decreasing, there is still widespread fear and misinformation about the disease.
В любими на 0 потребителя · Гледания от други сайтове:
Графиката се генерира моля проверете след няколко секунди.